[email protected]
T: 0216 593 37 40
F: 0216 593 37 41

TR / EN

Previous
Next
  1. Home
  2. »
  3. Basın Bülteni
  4. »
  5. BEESEBA WINS AWARD AT 9TH INTERNATIONAL PHARMACEUTICAL CHEMISTRY CONGRESS

BEESEBA WINS AWARD AT 9TH INTERNATIONAL PHARMACEUTICAL CHEMISTRY CONGRESS

Participation in the “9th International Pharmaceutical Chemistry: Pharmaceutical Active Substance Design, Synthesis, Production and Standardization Congress” held on 8-11 April 2021, with the poster presentation of two products developed at the Arion Pharmaceuticals R&D Center. Our poster titles are:

Investigation of the Efficacy of Beeseba in Naturally Infected Honey Bee Colonies with Vairimorpha (Nosema) ceranae
Investigation of the Efficacy of Some Essential Oil Compounds in Dogs Naturally Infected with Scabies

The presentations were made by Arion Pharmaceuticals General Manager Mr. Yigit Altav and Dr. Suna Aslı Zengin has done it. ARION Pharmaceuticals R&D Center was deemed worthy of honorable mention among 50 R&D projects with the BEESEBA product it developed. The success of our product was appreciated at the congress, where the deep-rooted companies of the Turkish Pharmaceutical Industry and universities showed great interest and participation.

Beeseba Liquid Premix
Our innovative product developed against NOSEMOSIS disease, which causes significant yield loss in bees, contains B vitamins and plant essential fatty acids that bees need.

While the efficacy rates obtained with chemical drugs remained at 70%, the effectiveness rate of 99% against Nosemosis was reached with BEESEBA®.
Since it does not contain chemicals, it protects both the environment, animal and human health.
Prevents chemical residue in honey.

Bulletin